BioSpace News Archive

Business

AMAG Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Highlights

Total GAAP revenue for the third quarter of 2017 increased to $153.7 million, 7% higher than the same period last year.

November 2, 2017
·
30 min read
Policy

Galapagos Moving Forward in CF Programs at NACFC 2017

Ten posters and four oral presentations reflect progress toward triple combination therapy.

November 2, 2017
·
5 min read
Basilea Reports on Commercial Progress of Antifungal Cresemba in Europe

Pfizer is now commercializing the product in the major EU markets and Austria.

November 2, 2017
·
4 min read
Business

TCR2 Therapeutics Appoints Cell Therapy Pioneer Dr. Stephan Grupp to Advisory Board

“Dr. Stephan Grupp has helped to revolutionize T cell immunotherapy and we are thrilled to welcome him to TCR2’s Advisory Board,” said Mitchell Finer, PhD, Chairman of TCR2’s Advisory Board and Member of the company’s Board of Directors.

November 2, 2017
·
3 min read
Tigenix Strengthens European IP Protection Around Lead Development Program Cx601

The use of Cx601 in treating fistulas is protected by European patent EP 2292737 entitled “Use of adipose tissue-derived stromal stem cells in treating fistula”.

November 2, 2017
·
6 min read
Argenx to Host KOL Breakfast Symposium on Pemphigus Vulgaris on November 10, 2017

The event will feature guest speaker Dr. John Stanley, M.D., University of Pennsylvania School of Medicine, who will highlight the treatment landscape and unmet need in PV.

November 2, 2017
·
3 min read
Deals

Allena Pharma Announces Pricing of Initial Public Offering

The company announced the pricing of its initial public offering of 5,333,333 shares of common stock at a public offering price of $14.00 per share.

November 2, 2017
·
2 min read
Deals

Intellia Therapeutics Announces Pricing of Public Offering of Common Stock

The company announced the pricing of an underwritten public offering of 6,250,000 shares of its common stock at a public offering price of $24.00 per share, before underwriting discounts.

November 2, 2017
·
3 min read
Business

GN Store Nord: Interim Report Q3 2017: Continued Solid Organic Revenue Growth Drives Strong EBITA Growth

GN Store Nord delivered 7% organic revenue growth in Q3 2017. Revenue growth was 8% including impact from development in foreign exchange rates and M&A.

November 2, 2017
·
2 min read
Genetown

Fresenius Medical Care Showcases Global Research Leadership at World’s Largest Gathering of Kidney Professionals

Fresenius Medical Care announced that company researchers and clinical experts from across the globe will present 77 research abstracts at the 2017 American Society of Nephrology’s (ASN) Kidney Week Symposium.

November 2, 2017
·
5 min read